Virios Therapeutics Inc (VIRI)

[McMagyar]

10,000,000 share are the float..
A fair and decent number of trading shares.
Doesn’t explain 111,000,000 trading in one day…?

So.. how is this possible?
People have sold shares that don’t exist..
And people have bought shares that don’t exist..
They still own them
They still have sold them..

So what happens next?

Thurs we have shareholder meeting with finance update( usually company update as well)..

June we have phase 1 toxicology and efficacy update on drug 2..

Company came out at $.50 share..
So most shareholders Probabaly bought
Held and bought more once fda agreed to phase 3..

Short sellers probably saw % gain and thought easy money..

So here we are..

What is the value of phase 3 drug in humans? $200,000,000..is first stop..
$10 per share..what is the cost of 2 phase 3 Clinicals in humans? $20,000,000?

The company has to make a better case of the success they expect in treatment Naieve patients in phase 3 because of phase 2 outlier data! Otherwise the cost of capital while not outrageous will still be disappointingly dilutive at this price level.

It would be nice if one of the longer term shareholders explained in layman terms what the positive signal the company is focused upon…